Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and H-1-MR spectroscopy compared with histology (subgroup in the RAXO trial)

RAXO Study Grp, A. Uutela, A. Ovissi, A. Hakkarainen, A. Ristimäki, N. Lundbom, R. Kallio, L. M. Soveri, T. Salminen, A. Algars, P. Halonen, R. Ristamaki, A. Nordin, R. Blanco Sequeiros, I. Rinta-Kiikka, E. Lantto, J. Virtanen, E. Paakko, E. Liukkonen, J. SaunavaaraP. Ryymin, E. Lammentausta, P. Osterlund, H. Isoniemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number100280
JournalESMO open
Volume6
Issue number4
Number of pages11
ISSN2059-7029
DOIs
Publication statusPublished - Aug 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • colorectal cancer
  • liver metastasis
  • neoadjuvant chemotherapy
  • liver surgery
  • diffusion-weighted imaging
  • magnetic resonance spectroscopy
  • PATHOLOGICAL RESPONSE
  • CHEMOTHERAPY
  • PREDICTION
  • TUMOR
  • BEVACIZUMAB
  • SURVIVAL
  • CRITERIA
  • OUTCOMES
  • SURGERY
  • FAT
  • 3122 Cancers
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this